Compagnie Lombard Odier SCmA’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53M | Sell |
|
|||||
|
2025
Q1 | $4.39M | Sell |
|
|||||
|
2024
Q4 | $5.83M | Buy |
|
|||||
|
2024
Q3 | $7.69M | Buy |
|
|||||
|
2024
Q2 | $9.1M | Sell |
|
|||||
|
2024
Q1 | $8.2M | Buy |
|
|||||
|
2023
Q4 | $5.85M | Buy |
|
|||||
|
2023
Q3 | $4.36M | Buy |
|
|||||
|
2023
Q2 | $3.76M | Buy |
|
|||||
|
2023
Q1 | $1.95M | Buy |
|
|||||
|
2022
Q4 | $780K | Sell |
|
|||||
|
2022
Q3 | $634K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $6K | Sell |
|
|||||
|
2017
Q3 | $1.1M | Hold |
|
|||||
|
2017
Q2 | $982K | Sell |
|
|||||
|
2017
Q1 | $833K | Buy |
|